Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Cellular/Molecular

The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors

Changhai Cui, T. K. Booker, Roberta S. Allen, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Outi Salminen, Theresa Tritto, Christopher M. Butt, W. R. Allen, Jerry A. Stitzel, J. Michael McIntosh, Jim Boulter, Allan C. Collins and Stephen F. Heinemann
Journal of Neuroscience 3 December 2003, 23 (35) 11045-11053; DOI: https://doi.org/10.1523/JNEUROSCI.23-35-11045.2003
Changhai Cui
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. K. Booker
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberta S. Allen
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon R. Grady
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Whiteaker
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Marks
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Outi Salminen
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theresa Tritto
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. Butt
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. R. Allen
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry A. Stitzel
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Michael McIntosh
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim Boulter
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan C. Collins
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen F. Heinemann
1Salk Institute for Biological Studies, La Jolla, California 92037, 2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, 3Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0930, 4Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah 84112, 5Department Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, California 90024, and 6Blanchette Rockefeller Neuroscience Institute, Rockville, Maryland 20850
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Published eLetters

Guidelines

As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
15 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

The Journal of Neuroscience: 23 (35)
Journal of Neuroscience
Vol. 23, Issue 35
3 Dec 2003
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Changhai Cui, T. K. Booker, Roberta S. Allen, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Outi Salminen, Theresa Tritto, Christopher M. Butt, W. R. Allen, Jerry A. Stitzel, J. Michael McIntosh, Jim Boulter, Allan C. Collins, Stephen F. Heinemann
Journal of Neuroscience 3 December 2003, 23 (35) 11045-11053; DOI: 10.1523/JNEUROSCI.23-35-11045.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Changhai Cui, T. K. Booker, Roberta S. Allen, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Outi Salminen, Theresa Tritto, Christopher M. Butt, W. R. Allen, Jerry A. Stitzel, J. Michael McIntosh, Jim Boulter, Allan C. Collins, Stephen F. Heinemann
Journal of Neuroscience 3 December 2003, 23 (35) 11045-11053; DOI: 10.1523/JNEUROSCI.23-35-11045.2003
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • β3 neuronal nicotinic receptor
  • gene knock-out
  • striatal dopamine release
  • α-conotoxin MII
  • locomotor activity
  • prepulse inhibition of acoustic startle

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Innexin-Mediated Adhesion between Glia Is Required for Axon Ensheathment in the Peripheral Nervous System
  • Transient and Sustained Ganglion Cell Light Responses Are Differentially Modulated by Intrinsically Produced Reactive Oxygen Species Acting upon Specific Voltage-Gated Na+ Channel Isoforms
  • Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.